Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Bladder cancer

ASCO endorses EAU muscle-invasive bladder cancer guidelines

Nature Reviews Urology volume 13, pages 440–441 (2016)Cite this article

Subjects

A multidisciplinary expert panel from the American Society of Clinical Oncology has endorsed the updated European Association of Urology guidelines for the management of muscle-invasive bladder cancer, with one exception. The panel also provides additional clarification of several recommendations.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Milowsky, M. I. et al. Guideline on muscle-invasive and metastatic bladder cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J. Clin. Oncol. 34, 1945–1952 (2016).

    Article  Google Scholar 

  2. Nayan, M. et al. The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: a time-series analysis. Can. Urol. Assoc. J. 10, 25–30 (2016).

    Article  Google Scholar 

  3. International collaboration of trialists. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. Lancet 354, 533–540 (1999).

  4. Grossman, H. B. et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N. Engl. J. Med. 349, 859–866 (2003).

    Article  CAS  Google Scholar 

  5. Bochner, B. H. et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur. Urol. 67, 1042–1050 (2015).

    Article  Google Scholar 

  6. Smith, N. D. et al. The RAZOR (randomized open versus robotic cystectomy) trial: study design and trial update. BJU Int. 115, 198–205 (2015).

    Article  Google Scholar 

  7. Gray, P. J. et al. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Eur. Urol. 63, 823–829 (2013).

    Article  Google Scholar 

  8. Choi, W. et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25, 152–165 (2014).

    Article  CAS  Google Scholar 

  9. Van Allen, E. M. et al. Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Cancer Discov. 4, 1140–1153 (2014).

    Article  CAS  Google Scholar 

  10. Chou, R. et al. Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer (Agency for Healthcare Research and Quality (US), 2015).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Seth P. Lerner is at the Scott Department of Urology, Baylor College of Medicine, 7200 Cambridge Street, Houston, Texas 77030, USA.,

    Seth P. Lerner

Authors
  1. Seth P. Lerner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seth P. Lerner.

Ethics declarations

Competing interests

S.L. has worked with BioCancell, Vaxxion Therapeutics, UroGen Pharma, Telesta Therapeutics, Sitka Biopharma, Neucleixx, Taris Biomedical, Ferring Pharmaceuticals and the Bladder Cancer Journal. He has received grants from ENDO Intenational, FKD Therapies, Viventia Bio, Roche, Genentech and Genome DX.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lerner, S. ASCO endorses EAU muscle-invasive bladder cancer guidelines. Nat Rev Urol 13, 440–441 (2016). https://doi.org/10.1038/nrurol.2016.114

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2016.114

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing